Mast Cell Activation Syndrome Assessment

MCAS symptom evaluation across dermatological, gastrointestinal, cardiovascular, respiratory, and neurological systems, with trigger identification.

Scoring

Instrument: Symptom Score — a cumulative symptom-severity score across multiple organ systems, with trigger pattern analysis.

What it covers

Demographics; symptom overview; dermatological symptoms; gastrointestinal symptoms; cardiovascular symptoms; respiratory symptoms; neurological symptoms; triggers and patterns; laboratory results; and current treatment.

Common pitfalls

• Diagnosing from symptom pattern alone without laboratory correlation — MCAS diagnostic criteria typically require objective evidence of mast cell mediator release (e.g. tryptase) correlated temporally with symptomatic episodes, not symptoms alone.
• Missing anaphylaxis risk within the broader symptom picture — a severe MCAS episode can present as or progress to anaphylaxis; the assessment should flag this risk distinctly rather than treating it as just one more symptom entry.
• Treating multi-system symptoms as unrelated separate complaints — the value of a cross-system assessment is recognizing when dermatological, GI, cardiovascular, respiratory, and neurological symptoms cluster together in a pattern consistent with mast cell activation, rather than working each up independently.

Learn more

• FormExamples: mast-cell-activation-syndrome-assessment for the full implementation, clinical references, and worked examples.
• Allergy Assessment for the related allergy/anaphylaxis-focused assessment.